Composition
- Active ingredients
- ERYTHROMYCIN 250MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ERYTHROMYCIN 250MG · Tablet, delayed releaseThis page
- ERYTHROMYCIN 0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · OintmentNDA050368-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA061910.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Ilotycin
- Active substance
- erythromycin
- Route
- Oral
- Dosage form
- Tablet, delayed release
- Applicant
- Dista
- Status
- Discontinued
- FDA approval
- 27 Feb 1975
- Application
- ANDA061910-001